Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells

Hua Yu, Richard Jove, The STATs of cancer — new molecular targets come of age Nature Reviews Cancer. ,vol. 4, pp. 97- 105 ,(2004) , 10.1038/NRC1275

Jennifer S. Ko, Arnold H. Zea, Brian I. Rini, Joanna L. Ireland, Paul Elson, Peter Cohen, Ali Golshayan, Patricia A. Rayman, Laura Wood, Jorge Garcia, Robert Dreicer, Ronald Bukowski, James H. Finke, Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients Clinical Cancer Research. ,vol. 15, pp. 2148- 2157 ,(2009) , 10.1158/1078-0432.CCR-08-1332

Pingyan Cheng, Cesar A. Corzo, Noreen Luetteke, Bin Yu, Srinivas Nagaraj, Marylin M. Bui, Myrna Ortiz, Wolfgang Nacken, Clemens Sorg, Thomas Vogl, Johannes Roth, Dmitry I. Gabrilovich, Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein Journal of Experimental Medicine. ,vol. 205, pp. 2235- 2249 ,(2008) , 10.1084/JEM.20080132

Tianhong Wang, Guilian Niu, Marcin Kortylewski, Lyudmila Burdelya, Kenneth Shain, Shumin Zhang, Raka Bhattacharya, Dmitry Gabrilovich, Richard Heller, Domenico Coppola, William Dalton, Richard Jove, Drew Pardoll, Hua Yu, Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Medicine. ,vol. 10, pp. 48- 54 ,(2004) , 10.1038/NM976

Maciej Kujawski, Marcin Kortylewski, Heehyoung Lee, Andreas Herrmann, Heidi Kay, Hua Yu, Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. Journal of Clinical Investigation. ,vol. 118, pp. 3367- 3377 ,(2008) , 10.1172/JCI35213

Sandrine Faivre, George Demetri, William Sargent, Eric Raymond, Molecular basis for sunitinib efficacy and future clinical development Nature Reviews Drug Discovery. ,vol. 6, pp. 734- 745 ,(2007) , 10.1038/NRD2380

Marco Seandel, Jinru Shia, Irina Linkov, Robert G. Maki, Cristina R. Antonescu, Jakob Dupont, The activity of sunitinib against gastrointestinal stromal tumor seems to be distinct from its antiangiogenic effects. Clinical Cancer Research. ,vol. 12, pp. 6203- 6204 ,(2006) , 10.1158/1078-0432.CCR-06-1292

John D. Gordan, Jessica A. Bertout, Cheng-Jun Hu, J. Alan Diehl, M. Celeste Simon, HIF-2α promotes hypoxic cell proliferation by enhancing c-Myc transcriptional activity Cancer Cell. ,vol. 11, pp. 335- 347 ,(2007) , 10.1016/J.CCR.2007.02.006

Jacqueline F Bromberg, Melissa H Wrzeszczynska, Geeta Devgan, Yanxiang Zhao, Richard G Pestell, Chris Albanese, James E Darnell, Stat3 as an Oncogene Cell. ,vol. 98, pp. 295- 303 ,(1999) , 10.1016/S0092-8674(00)81959-5

Robert A Figlin, Thomas E Hutson, Evolving role of novel targeted agents in renal cell carcinoma. Oncology. ,vol. 21, pp. 1175- 1180 ,(2007)